Primary Site >> Liver Cancer

Gene >> ENPP3

  • 1976
  • 1997
  • 2000
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells.
PMID: 176270
Ref: Differences between graft-versus-leukemia and graft-versus-host reactivity. I. Interaction of donor immune T cells with tumor and/or host cells.
PMID: 9058744
Ref: Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity.
PMID: 10815924
Ref: Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
PMID: 17597105
Ref: Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
PMID: 18056116
Ref: Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.
PMID: 19236911
Ref: Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
PMID: 20036025
Ref: Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS.
PMID: 21472284
Ref: AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.
PMID: 21640744
Ref: A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals.
PMID: 22355790
Ref: SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
PMID: 23665285
Ref: Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis.
PMID: 24747592
Ref: [Malignant transformation of glioma stromal cells induced by glioma stem cells heterotopically inoculated in host liver].
PMID: 25533989
Ref: Regulation of aldo-keto-reductase family 1 B10 by 14-3-3epsilon and their prognostic impact of hepatocellular carcinoma.
PMID: 26516929
Ref: AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma.
PMID: 26589436
Ref: Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
PMID: 26758591
Ref: Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery.
PMID: 27387388
Ref: Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.
PMID: 28105190
Ref: Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk.
PMID: 27084455
Ref: Immunohistochemistry Detects Increased Expression of Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) in Early-Stage Hepatocellular Carcinoma.
PMID: 30328412